XML 17 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows provided by operating activities:    
Net income $ 541,032 $ 382,499
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Net realized (gains) losses on sale of investments (80,436) 67,494
Depreciation and amortization 283,828 235,662
Amortization of bond premium, net 92,646 80,220
Stock-based compensation 32,234 38,892
Excess tax benefit from exercise of stock options 0 (221,136)
Deferred income tax expense (43,114) (9,856)
(Increase) decrease in operating assets:    
Premiums receivable, net 99,464 (481,267)
Receivables - reinsurance contracts 0 (134,656)
Reinsurance receivables, net (4,560,111) (976,328)
Deferred policy acquisition costs (141,970) (49,985)
Other assets (666,404) 177,501
Increase (decrease) in operating liabilities:    
Loss and loss adjustment expense reserves 6,154,265 2,238,581
Unearned premiums 122,858 468,420
Advance premiums 532,486 407,514
Reinsurance balances payable 1,536,971 (77,807)
Deferred ceding commission revenue (18,859) (53,978)
Accounts payable, accrued expenses and other liabilities (1,212,176) (1,257,693)
Net cash flows provided by operating activities 2,672,714 834,077
Cash flows used in investing activities:    
Purchase - fixed-maturity securities available-for-sale (15,890,742) (3,349,181)
Purchase - equity securities available-for-sale (1,831,513) (1,145,558)
Sale or maturity - fixed-maturity securities available-for-sale 6,401,092 716,892
Sale - equity securities available-for-sale 1,161,501 0
Acquisition of fixed assets (182,164) (165,829)
Other investing activities 250,448 3,170
Net cash flows used in investing activities (10,091,378) (3,940,506)
Cash flows used in financing activities:    
Withholding taxes paid on net exercise of stock options 0 (243,662)
Excess tax benefit from exercise of stock options   221,136
Purchase of treasury stock (95,881) (128,763)
Dividends paid (457,603) (365,505)
Net cash flows used in financing activities (553,484) (516,794)
Decrease in cash and cash equivalents (7,972,148) (3,623,223)
Cash and cash equivalents, beginning of period 13,551,372 9,906,878
Cash and cash equivalents, end of period 5,579,224 6,283,655
Supplemental disclosures of cash flow information:    
Cash paid for income taxes 30,000 300,500
Supplemental schedule of non-cash investing and financing activities:    
Value of shares deducted from exercise of stock options for payment of withholding taxes $ 0 $ 243,662